Pharmaceutical
Stem Cell Therapeutics Corp. announced today it has been advised by the Data Safety Monitoring Board that a regularly scheduled safety analysis has been completed and the DSMB has recommended the Phase IIb stroke trial to continue as per the ...
34 hours ago
Pfizer announced today that the U.S. Food and Drug Administration has approved Revatio Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 inhibitor available in both tablet and intravenous ...
34 hours ago
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use , the scientific committee of the European Medicines Agency , has formally adopted a negative opinion on the marketing authorization application for Oncophage ...
34 hours ago
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense Injection, administered for the first ...
35 hours ago
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in ...
35 hours ago
OPTIMIZERx Corporation has engaged Beringea LLC, an investment banking and private equity firm, to assist in financial planning and strategic positioning for the company's continued growth.
35 hours ago
Covidien , a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has set a new action date under the Prescription Drug User Fee Act for the review of the New Drug Application for Exalgo Tablets ...
35 hours ago
LAVAL, QC , Nov. 20 /PRNewswire-FirstCall/ - Labopharm Inc. today announced that James R. Howard-Tripp, President & Chief Executive Officer of the Company, will present at the Dundee Emerging Growth Summit at the Design Exchange in Toronto , on ...
36 hours ago
Soligenix, Inc. , formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax and other rapidly acting vaccines. Soligenix received a ...
36 hours ago
New data released today by Quest Diagnostics Incorporated , the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S. workforce has ...
36 hours ago
Smith & Nephew Orthopaedics Division is pleased to announce the signing of a technology development contract with the United States Department of Defense that may lead to the creation of a fracture fixation system intended to revolutionize the ...
36 hours ago
Sabrina Cohen, founder of The Sabrina Cohen Foundation for Stem Cell Research , was just recognized as a WebMD 2009 Health Hero. She will receive national media attention with a full-page article about her personal story of triumph and courage, and ...
36 hours ago
BeaconEquity.com announces an investment report featuring biopharmaceutical company Vivus Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
36 hours ago
Research and Markets has announced the addition of the 'Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry' report to their offering.
37 hours ago
Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses ...
37 hours ago
31 - 45 of 73669 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
